The mechanism of MET action in DM patients on HCC prevention and treatment is supposed to be related to the AMPK pathway, whereas MET activates AMPK expression by increasing the cellular energy stress, which triggers insulin/IGF-1 signaling inhibition that is involved in the control of cancer glycolysis and carcinogenesis [23]. This evidence concerns the gene PRKAA1 and cancer.